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Abstract
The possible signaling role of prokineticin 2 (PK2) and its receptor, prokineticin receptor 2 (PKR2), on female reproduction
was investigated. First, the expression of PKR2 and its co-localization with estrogen receptor (ERa) in the hypothalamus was
examined. Sexually dimorphic expression of PKR2 in the preoptic area of the hypothalamus was observed. Compared to the
male mice, there was more widespread PKR2 expression in the preoptic area of the hypothalamus in the female mice. The
likely co-expression of PKR2 and ERa in the preoptic area of the hypothalamus was observed. The estrous cycles in female
PK2-null, and PKR2-null heterozygous mice, as well as in PK2-null and PKR2-null compound heterozygous mice were
examined. Loss of one copy of PK2 or PKR2 gene caused elongated and irregular estrous cycle in the female mice. The
alterations in the estrous cycle were more pronounced in PK2-null and PKR2-null compound heterozygous mice. Consistent
with these observations, administration of a small molecule PK2 receptor antagonist led to temporary blocking of estrous
cycle at the proestrous phase in female mice. The administration of PKR2 antagonist was found to blunt the circulating LH
levels. Taken together, these studies indicate PK2 signaling is required for the maintenance of normal female estrous cycles.
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Introduction
The estrous cycle is an important characteristic of the
mammalian female reproductive system. It is known that the
estrous cycle in female rodents is under the control of both the
circadian clock and hormonal changes [1]. A gonadotrophin-
releasing hormone (GnRH) surge released from the hypothalamus
before estrus is required to induce the pituitary to release
luteinizing hormone (LH) and follicle stimulating hormone
(FSH), which then influence estrous cycling. Coordinated GnRH
release on the afternoon of proestrus requires both a daily timing
signal originating from the suprachiasmatic nucleus (SCN) and
permissive levels of estrogen and progesterone[2]. During the
follicular phase of the ovarian cycle, estrogen gradually increases.
As the dominant follicle continues to grow and develop, there is a
change from relative inhibition of GnRH secretion to a positive
concerted stimulation, resulting in the surge release of LH from
the pituitary and subsequent ovulation of mature oocytes. In mice
and rats, the LH surge commences in the afternoon with ovulation
occurring in the middle of the night [1]. SCN lesion results in the
loss of the gating response to elevated estrogen in rats[3].
Consistent with the proposed gating effect of SCN clock,
prolonged and irregular estrous cycles has been reported in
Bmal1-null mice that are deficient in circadian rhythms[4,5].
The loss of circadian LH secretion and reproductive cycles
abolished by the SCN lesion are not restored by SCN transplants
[6], indicating specific neural efferents from the SCN might carry
the output signal for the timing of the GnRH release. At the
molecular level, several secretory molecules (vasopressin, vasoac-
tive intestinal polypeptide, PK2, and cardiotrophin) have been
shown to function as signaling molecules that convey SCN timing
to the generation of overt circadian rhythms such as locomotor
and sleep/wake cycles, body temperature and metabolic rhythms
[6–11]. Of these, vasopressin and vasoactive intestinal polypeptide
have been implicated as the SCN output signals that link the SCN
clock to the normal expression of female estrous cycle [1,2,7,8].
A series of studies, including gene disruption, have established
PK2 as a SCN output molecule that is required for normal
expression of circadian rhythms [10,12,18]. The disruption of PK2
and PKR2 genes has revealed an unexpected developmental role
of PK2/PKR2 signaling in sexual maturation [13,14]. As PK2
signaling via PKR2 is essential for the morphogenesis of the
olfactory bulb (OB), and the OB is part of the migratory path of
GnRH neurons from the nasal cavity to the hypothalamus,
migration of GnRH neurons to their final hypothalamic destiny is
blocked in the absence of PK2/PKR2 signaling. Therefore, PK2-
null and PKR2-null mice exhibit hypogonadotropic hypogonad-
ism and hypoplasia of reproductive organs in both male and
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mutations has also been verified by diverse studies of human
hypogonadism carried out by several laboratories [13,14,15,16].
However, the expression of PKR2 in the preoptic area of the
hypothalamus of adult mice suggests that PK2 signaling may have
a direct signaling role in the control of the reproductive axis [10],
in addition to its indirect developmental effect. This notion was
also supported by the observations that human subjects with
heterozygous mutations in PK2 or PKR2 presented with complete
isolated GnRH deficiency[17]. These studies have implicated a
possible signaling role of PK2 in the normal control of
reproduction, in addition to its role in the development of GnRH
neurons.
The developmental defect of GnRH neurons in PK2-null as
well as PKR2-null mice has precluded the use of such completely
null mutant mice to examine the signaling role of PK2 at adult-
stage physiology. We thus examined the estrous cycle alterations in
heterozygous PK2-null and PKR2-null mice, as well in PK2-null
and PKR2-null compound heterozygous mice. We also took
advantage of a newly developed small molecule PKR2 antagonist
to explore the PK2 signaling roles in the reproductive axis of
female mice.
Figure 1. The sexually dimorphic expression of PKR2 in the preoptic area of hypothalamus. The PKR2 expression was observed with
PKR2-GFP transgenic mice. Panel A shows the sexually dimorphic expression of PKR2 was apparent (scale bars:100 mm, AC: Anterior Commissure).
Panel B shows Comparison of the number of PKR2-positive cells in females and males in the region of AVPV.
doi:10.1371/journal.pone.0090860.g001
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Mice and housing conditions
Mice were maintained in regular 12 h light (ZT0-ZT12): 12 h
dark cyles (ZT12-ZT24) with light on at 6 AM. The light intensity
of mouse housing cages was ,250 lux, with room temperature set
at 21uC. Mice have free access to standard food chow (fat content
5–10% of energy). The PK2-null and PKR2-null mice were
backcrossed to a C57Bl6 background for at least seven genera-
tions, as described previously [12,18]. PKR2-GFP transgenic mice
were generated in mouse strain FVB/N as described [19].
Genotyping of mice was performed by PCR analysis of DNA
samples from tail biopsies. The control mice of all experiments
were littermates. Female and male mice for the study were
separately housed, and were 3–5 months of age. For PKR2
expression studies, male and female PKR2-GFP transgenic mice
were sacrificed at 10 AM (ZT4). Female PKR2-GFP transgenic
mice were sacrificed when they were in diestrous stage. All studies
were approved by Institutional Animal Care and Use Committee
of University of California,Irvine. Every possible effort has been
undertaken to mitigate the animal suffering.
Cytologic evaluation of the estrous cycles
Stages of the estrous cycle were determined by cytologic
evaluation of vaginal smears. Briefly, sterile saline buffer was
gently flushed into the vagina using soft plastic pipettes between
10 AM (ZT4) and 12 noon (ZT6) daily. The lavages were smeared
on glass slides and examined microscopically to evaluate the
cytologic features. The stages of the estrous cycle were determined
based on the presence or absence of leukocytes, cornified
epithelial, and nucleated epithelial cells, as described by Byers
S.L.[20]. Regular estrous cycles appeared as constant P-E-M-D
records, and the average cycle length was 4–5 days. Irregular
estrous cycles presented as interrupted cycles and could stay on
any of the four stages for more than two days. When the cycle
stayed on one stage for more than four or five days without
change, this was recorded as non-cycling or missing estrous
cyclicity. Daily observations ensured at least three consecutive
cycles in each animal.
Administration of PKR2 antagonist
To observe the effect of PK2 receptor antagonist on the estrous
cycle, PK2 receptor antagonist (3Cl-MPL) or vehicle (sunflower
oil, Sigma, with injection volume of 100 microliter) were delivered
subcutaneously at the dose of 10 mg/kg at 10 AM (ZT4) on the
day of the proestrous. The PK2 receptor antagonist, 3Cl-MPL,
was synthesized as described [21]. Antagonist potency was
measured by an aequorin-based Ca2+ luminescent assay in
CHO cells (Chinese Hamster Ovary) that stably expressed the
photoprotein aequorin and PKR2, as described previously [22].
Histological studies
Expression studies of ERa (estrogen receptor a) and PKR2 was
carried out as described [15]. Briefly, mice were perfused
intracardially with 50 ml 16 PBS (2.7 mM KCl; 1.8 mM
KH2PO4; 10.1 mM Na2HPO4; 137 mM NaCl) followed by
50 ml 4% paraformaldehyde in 16 PBS. Brains were then post-
fixed at 4uC for 24 hours in the same fixative, cryoprotected in
30% sucrose in 16 PBS for 24 to 48 hours. 40 mm coronal
sections were first blocked in PBS containing 0.2% Triton X-100
(PBST) plus 10% horse serum, then incubated with rabbit anti-
ERa (1:150; HC-20, Santa Cruz Biotechnology) in PBST
containing 3% horse serum at 4uC overnight. Donkey anti-rabbit
IgG (1:200, Jackson ImmunoResearch, West Grove, PA) was
added after primary antibody incubation. Immunofluorescence for
PKR2-GFP-expressing neurons was performed similarly except
that the first antibody was chicken anti-GFP (1:1000, Invitrogen,
Carlsbad, CA) and secondary antibody was goat-anti-chicken IgG
(1:300, Jackson ImmunoResearch). Sections were counter-stained
with DAPI (Vector Laboratories) and viewed with a Zeiss
(Oberkochen, Germany) fluorescence microscope. Immunofluo-
rescence for GnRH expressing neurons are the same as for ERa
expressing neurons described above, except the first antibody was
rabbit anti-GnRH(1:5,000; Chemicon, Temecula, CA) instead.
Hormonal assay
Animals receiving one subcutaneous injection of 10 mg/kg
PKR antagonist (3-Cl-MPL) or vehicle (sunflower oil) at 10 AM
(ZT4) on the day of proestrous were sacrificed at light-off (ZT12)
and blood was collected from the trunk. LH levels were measured
Figure 2. PKR2 antagonist reduced plasma LH levels (Mean ± S.E.). The LH levels in the PKR2 antagonist (10 mg/kg 3Cl-MPL) group were
significantly reduced compared to the vehicle treatment (n=6 for each group, p,0.01.
doi:10.1371/journal.pone.0090860.g002
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Specialized Cooperative Center for Research in Reproduction at
the University of Virginia (Charlottesville, VA). The linear range
of the LH assay was 0.04–37.4 ng/ml, and the intra-assay
coefficient of variation was 7%.
Cell counting
Only cells with positive signals stronger than the background
were tallied for quantification. Background signals were defined by
random sampling in the no staining areas of sections as well as the
surrounding areas. Cell counts were performed by counting all
cells within the boundaries of the preoptic area in each section as
described [23].
Statistical analyses
Results were expressed as the mean 6 SE. All statistical analyses
were performed using Graphpad Prism 5. Differences between
groups were examined for statistical significance by using one-way
ANOVA followed by Dunnett’s test (Fig.1 an Fig.2), or a two-way
ANOVA for groups comparison (Fig.3 and Fig.4). P,0.05 was
considered statistically significant.
Results
We have previously shown that PKR2 is expressed in the
preoptic area [24]. To further demonstrate PK2 signaling may
regulate female reproduction, we carried out the detailed analysis
of PKR2 expression in the preoptic area in both males and
females. To facilitate the expression studies, we also used a line of
transgenic mice with the reporter gene GFP under the control of
PKR2 promoter [19]. As shown in Fig. 1A, there clearly existed
sexually dimorphic expression of PKR2 in the preoptic area.
Compared to male mice, females have much more widespread
PKR2-expressing neurons in the preoptic area. Quantitative
analysis indicated there was about six times more PKR2-positive
cells in females than males in the AVPV (anterior ventral
periventricular area) (Fig. 1B). Using dual-immunoflourescence
studies, we further showed that some PKR2-expressing neurons
Figure 3. Abnormality of estrous cycle in PK2, PKR2 single and compound heterozygotic female mice. Three female mice in wild-type
group, six female mice in each three mutant groups were studied. Panel A shows that three mutant groups exhibited irregular and longer estrous
cycles compared to the wild-type control. PKR2 heterozygotes and the compound heterozygous female mice exhibited more pronounced
abnormality. Panel B shows the quantification of estrous cycle lengths (Mean 6 S.E.), * p,0.05 ** p,0.01. Panel C shows the percentage of days at
each stage in 20 days of observance. D: diestrus, M: metestrus, E: estrus, P: proestrus.
doi:10.1371/journal.pone.0090860.g003
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explicit cellular colocalization of PKR2 and Era has not been
resolved, they are at least expressed in the AVPV (Fig. 5). The
sexually dimorphic expression of PKR2 in the preoptic area and
the likely co-localization with ERa suggests that PK2/PKR2
signaling may play a signaling role in the reproductive axis.
We, and others, have developed mutant mice that are deficient
in PK2 or PKR2 genes [12,18]. As the developmental defect of
GnRH neurons in PK2-null as well as PKR2-null mice precludes
the use of such null mutant mice for the analysis of a signaling role
at adult-stage physiology, we carefully examined the estrous cycle
of mutant mice with loss of a single copy of PK2 or PKR2 (Fig.3).
Compared to wild-type, littermate controls, PK2+/2 mice
displayed slightly increased estrous cycle length (5.461.9 days),
compared to controls (4.560.5 days). PKR2+/2 mice exhibited
significantly more abnormal estrous cycles, with the mean estrous
cycle length (7.763.5 days, P,0.05). The PK2+/2, PKR2+/2
double heterozygous mice showed the most severe phenotype,
with all female mice exhibiting anomalous cycles (either longer, or
irregular cycles or completely non-cycling). Average estrous cycle
length in these double-heterozygous mice (8.864.8 days) was
nearly twice as long as that of wild type females (p,0.01). In
particular, we observed elongated diestrous stages in double-
heterozygous mice, and four out of six females were essentially
non-cycling. The increased severity in double heterozygous mice,
compared to that of single PK2 or PKR2 heterozygous mice, is
consistent with the interaction of PK2 with PKR2. Previous
studies have revealed about 50% reduction in the expression levels
of PK2 or PKR2 in heterozygous mice [18]. The coincident
reduction of expression of both PK2 and PKR2 genes would then
result in aggregate defect in PK2-PKR2 signaling, and thus more
pronounced deficit in the estrous cycles.
To rule out the possible involvement of any developmental
defects of GnRH neurons, we documented that cell counts of
GnRH neurons within the hypothalamus in WT, PK2, PKR2
single- and compound-heterozygous female mice. As shown in
Fig. 4, cell counts of GnRH neurons in these single- and
compound-heterozygous female mice were not significantly
different, indicating that the abnormality of estrous cycling was
not due to any gross developmental defect. Recently, we have
developed a series of PKR2 antagonists [29,30], which permits
blockade of PKR2 signaling without any confounding effects on
development. These antagonists inhibit the signaling of PK2-
stimulated calcium mobilization in Chinese Hamster Ovary
(CHO) cells that stably express PKR2 with high potency. One
such PKR2 antagonist, 3Cl-MPL, with IC50 of 24.964.3 nM for
PKR2, was used for the current study (Fig. 6). We tested the effect
of 3Cl-MPL on the function of female reproductive cycle by
administering a single dose of PKR2 antagonist in the morning of
the proestrous stage to wild type C57BL6 mice. Figure 7 shows
that, in contrast to the vehicle control, PKR2 antagonist led to the
temporary blockade of estrous cycle in essentially all animals.
Particularly, the proestrous phase was elongated at the cost of the
estrous phase (Figure 7). This effect is in line with the alterations
observed in the estrous cycles of PK2 or PKR2 single- and
Figure 4. Cell counts of GnRH neurons in WT, PK2, PKR2 single and compound heterozygotic female mice(Mean ± S.E.). Two-way
ANOVA with Bonferroni post-test showed no significant difference among all four groups.
doi:10.1371/journal.pone.0090860.g004
Figure 5. The coexpression of PKR2 and ERa in the preoptic
area. PKR2 and ERa were detected by immunofluorescence
staining. PKR2-GFP expression was shown in green and ERa
expression was shown in red. Yellow or orange color in the MnPO
and AVPV regions indicates likely co-expression of PKR2 and ERa (scale
bars:100 mm).
doi:10.1371/journal.pone.0090860.g005
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effect of PKR2 blockade on the LH levels by administering PKR2
antagonist. As shown in Figure 2, the LH levels at ,ZT12 in the
control group were 8.9163.83 ng/ml, while the LH level in the
group receiving antagonist were significantly reduced
(1.0960.74 ng/ml. P,0.01). This result indicates that adminis-
tration of the PKR2 antagonist reduced the circulating levels of
LH at the time of lights off, suggesting either a reduction in the
amplitude or a delay in the timing of the LH surge by PKR2
blockade.
Discussion
To maintain a normal estrous cycle is important for the fertility
of females. The pre-ovulatory GnRH surge is primarily controlled
by two types of inputs to GnRH neurons: hormonal feedback from
maturing ovarian follicles and circadian outputs from the SCN
[2,31,32]. On the afternoon of proestrus, a GnRH surge release
from the hypothalamus induces the pituitary to release LH and
FSH, which act on the ovary to induce ovulation and follicular
recruitment. SCN lesion studies and estrous cycle defects in the
Bmal1 null mice supported the importance of circadian output
from SCN for the normal expression of the estrous cycle[4].
Several signaling molecules, especially vasopressin and vasoactive
intestinal polypeptide, have been implicated as SCN output signals
that link to the reproductive axis [31,32,33,34].
The current studies investigated the effect of PK2, also
established as a SCN circadian clock output molecule
[10,17,18,35], in the normal expression of the estrous cycle in
female mice. The sexually dimorphic expression pattern of PKR2
and coexpression of PKR2 with ERa in the preoptic area suggest
that PK2-PKR2 signaling in the brain may likely be involved in
the regulation of the reprodutive cycle. We have obtained genetic
and pharmacological evidence to support this hypothesis. Loss of
one copy of PK2 and/or PKR2 genes caused elongated and
irregular estrous cycles in female mice, with the abnormality even
more pronounced in compound-heterozygous mice. Consistent
with this observation, pharmacological blockade of the PK2-
PKR2 signaling with a PKR2 antagonist led to the blunted
circulating LH levels and temporary blocking of the estrous cycle
in the majority of animals. Taken together, these observations
indicate PK2 signaling is needed for the normal expression of the
estrous cycle in female mice. A lower level of cycling still existed in
some compound-heterozygous females and antagonist-treated
mice, which is consistent with the notion that circadian signaling
is facilitatory, but not absolutely required for estrous cycles, i.e. in
the absence of circadian output signals, female cycling can occur in
some degree. While our results indicate the likely signaling role of
PK2 is due to the effect of PK2 as a SCN circadian clock output
molecule, PK2 is indeed expressed in several other brain areas,
and we could not rule out the possibility this effect of PK2 on the
regulation of female estrous cycle is due to non-SCN PK2.
The molecular mechanism of SCN output is an area of active
investigation. In addition to PK2, at least two other clock-
controlled regulatory peptides (vasopressin, and cardiotrophin)
may function as signaling molecules that convey SCN timing
Figure 6. Potency of PKR2 antagonist, 3Cl-MPL, in antagonizing PKR2. Antagonist potency was examined in Chinese Hamster Ovary (CHO)
cells that stably express PKR2. RLU is an index for calcium influx measurement with a luminescence-based assay. The IC50 of 3Cl-MPL for PKR2 were
24.964.3 nM(Mean 6 S.E.). Shown was representative of three independent experiments.
doi:10.1371/journal.pone.0090860.g006
Figure 7. Blocking of estrous cycle by PKR2 antagonist
treatment. The administration of 3Cl-MPL (shown in red arrows)
prevented the progression to estrous stage. Vehicle treatment was
shown by blue arrows. E: estrus, P: proestrus, D: diestrus, M: metestrus.
doi:10.1371/journal.pone.0090860.g007
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projecting from the SCN to the preoptic area [7,8,9], and
inhibition of vasopressin signaling on the morning of the
proestrous stage significantly attenuates LH release [8]. Further
genetic studies also indicated that reduced hypothalamic vaso-
pressin signaling plays a role in the proestrous LH surge [36]. The
majority of SCN neurons appears to use GABA as a neurotrans-
mitter[37], and the release of GABA during proestrus exhibits a
circadian pattern [38]. Though it is unclear how these clock-
controlled genes interact with each other or with GABA,
redundant circadian signals could regulate the GnRH surge,
underscoring the significance of a finely tuned reproductive cycle
that is adaptive to environmental cues.
GnRH neurons express the receptor for Kisspeptin (GPR54)
but not PKR2 [15,39,40]. Several studies have revealed that
up-regulation of Kisspeptins by estrogen in neurons of the AVPV
region preceeds the GnRH release that stimulates the LH surge
required for ovulation [25,26,41,42]. Kisspeptin could stimulate
GnRH release directly by binding to its receptor on GnRH
neurons [39,43,44]. The sexually dimorphic expression pattern of
PKR2 in the preoptic area is, however, very similar to that of
Kisspeptin which is known to play essential roles in stimulating the
pulsatile release of GnRH at puberty[25,26,27]. Moreover, some
neurons in the AVPV seem to coexpress PKR2 with ERa. Similar
co-expression pattern with estrogen receptor (ERa) was also
observed for the kisspeptin-expressing neurons[28]. As it has been
shown that the activity of Kisspeptin neurons in the AVPV exhibit
a circadian-controlled activity [33,45], it is thus intriguing to
examine whether PK2-PKR2 signaling could transmit the
circadian clock information to Kisspeptin-neurons in the AVPV
region for reproductive control.
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